Sri Lanka bans covering the face with veils after terror attacks

Bengaluru, Mar 5: Karnataka government on Thursday set aside Rs 400 crore to construct twin towers building with 25 floors here at Anand Rao Circle to facilitate all government departments to function at one place.

"To facilitate all the Government Departments to function in one building, a "Twin-Towers" building with 25 storeys will be constructed at Arland Rao Circle, Bengaluru, with an expenditure of Rs 400 crore," said Karnataka Chief Minister Yediyurappa while presenting the budget in the state Assembly.

He further said that the road cross-over facility for pedestrians other than metro commuters will be provided through 24 metro stations.

"The construction of 56 km long Outer Ring Road - Airport Metro from Central Silk Board junction to Bengaluru International Airport via K R Puram and Hebbala at an estimated cost of Rs 14,500 crore will be commenced during the year 2020-21," he said.

Rs 1,000 crore budget each have been announced for the restoration of Bengaluru roads for two years, 276 Karnataka public school for their infrastructure development.

Bareilly, Jun 22: The All India Tanzeem Ulama-e-Islam, a religious and social organisation headed by five senior clerics, has issued a fatwa to boycott Chinese products in the country.

The clerics said the community members should stand with the army and government in this hour.

Expressing concern over India-China face-off, National general secretary of All India Tanzeem Ulama-e-Islam, Maulana Shahbuddin Rizvi expressed concern over the India-China face-off and said, "A fatwa has been passed for boycotting Chinese products on a query posted by a Bareilly-based resident. The clerics in the fatwa have condemned the conspiracy of China to encroach upon Indian land and the killing of our brave soldiers."

The panel of five clerics include national president of All India Tanzeem Ulama-e-Islam Mufti Ashfaq Hussain Qadri, Mufti Iqbal Ahmad Misbahi, Mufti Tauqir Ahmad Qadri, Mufti Hashim Raza Khan and Qari Saghir Ahmad Rizvi.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.